Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration

• Status: Completed
• Trial end date: 2015-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluate a treatment result of every two months versus as needed (PRN) after 3 initial monthly intravitreal aflibercept for the Japanese age related macular degeneration.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Nihon University
• Treatments: Aflibercept

Criteria

Inclusion Criteria:

• Clinical diagnosis of age-related macular degeneration

Exclusion Criteria:

• Any treatment before intravitreal Aflibercept for age-related macular degeneration.

• Visual acuity above 0.1 in decimal visual acuity